Current Status and Alturas’ Ongoing Response to COVID-19
Updated 06OCT2020

MS/MS Services

Expert GLP & Non-GLP LC-MS/MS and GC-MS/MS bioanalytical and biomarker quantitation services in small and large molecules- from small volatiles, antibody drug conjugates, to protein therapeutics in any biological matrix. We provide on-time delivery of quantitative bioanalytical method development, transfer, and validation, and sample analysis to support drug candidates from discovery through phase IV clinical trials.

Learn more

MS/MS Research

Our reputation as a research-intensive organization keeps us at the front of new MS/MS bioanalytical techniques. In collaboration with technology leaders, Alturas has a successful history of transferring novel ideas to productive solution for the pharmaceutical industry. Alturas reserves resources for challenging assays and rush requests.

Learn more


A known pioneer in MicroFlow Liquid Chromatography (MFLC) and its applications to small and large molecule bioanalysis, and an active contributor in applying new microsampling techniques to routine sample analysis, recent and past publications, video, newsletters, and poster presentations produced by Alturas Analytics can be found here. We have an impressive history of leading the bioanalytical services industry with contributions from our research.

Learn more

Our Blog News & Events

  • We're Growing - Join Our Team!

    Join our team! Visit our website for more information on how to apply. Open positions:

    • Validation Associate
    • Project Coordinator
    • Associate Scientist
    • Laboratory Assistant
    • Specimen Management Technician

    View Alturas Careers

    Alturas Analytics Now Hiring
  • Applied Pharmaceutical Analysis 2020 Presentations

    Virtual Realities: Hosting Remote Audits (including the FDA) in a Post-COVID World
    Presented by David Schumacher, RQAP-GLP

    As the COVID-19 pandemic spread across the USA in early 2020, many facilities had to reduce operations, preventing auditors from traveling to customer sites. Alturas Analytics developed processes to permit auditors to conduct their inspections remotely. Additionally, Alturas Analytics was one of the first companies to be inspected remotely by the FDA in April. This presentation will present tips for a simple and positive remote audit experience and describe the process employed by the FDA to successfully complete a remote regulatory inspection.


    Ready, Willing, and Stable? Advice from the LC-MS Experts on Analysis of Unstable Compounds and Prodrugs
    Presented by Chad Christianson

    Prodrugs are pharmacologically inactive compounds that are converted to their active form by metabolism. While instability is beneficial for drug development, it creates challenges for the bioanalytical scientist. This presentation discusses multiple approaches to stabilize the prodrug.





Take a Tour

We're Hiring!